Petros Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $35.7M | $17.7M |
| Jun 2022 | — | $34.2M | $13.3M |
| Sep 2022 | — | $20.7M | $11.2M |
| Dec 2022 | — | $16.7M | $9.4M |
| Mar 2023 | — | $15.4M | $8.3M |
| Jun 2023 | — | $12.9M | $7.4M |
| Sep 2023 | — | $6.9M | $18.0M |
| Dec 2023 | — | $12.1M | $13.3M |
| Mar 2024 | — | $9.8M | $11.1M |
| Jun 2024 | — | $8.1M | $7.5M |
| Sep 2024 | — | $3.1M | $3.9M |
| Dec 2024 | — | $-7.5M | $1.7M |
| Mar 2025 | — | $-9.6M | $8.9M |
| Jun 2025 | — | $4.4M | $7.3M |
| Sep 2025 | — | $3.4M | $6.1M |
| Dec 2025 | — | $2.9M | $5.1M |
| Mar 2026 | — | $1.8M | $4.4M |
| Jun 2026 | — | $700.9K | $3.5M |